Showing Form 4 filings for HCAT
Pre-configured institutional-grade criteria for instant high-conviction screening
Multiple insiders buying stock within the last 30 days
Direct open-market purchases by Chief Executive Officers
Financial chiefs and top corporate officers accumulating shares
Institutional-scale insider purchases of $1,000,000 or greater
Insiders increasing their overall equity ownership by over 20%
High-value executive divestments by CEOs and CFOs over $1M
Health Catalyst, Inc.
Price
$1.42
Shares
99,478
Ownership
251,894
Value/Share
Landry Benjamin
GC
Unknown
Industry
HCAT
$1.79
59,000
2,856,385
Kohl Simeon
CEO
$2.67
47,997
73,573
Larson-Green Julie
Dir
$2.64
27,425
100,000
$3.35
6,175
141,812
$3.94
6,057
151,125
$4.10
5,209
205,832
Lesueur Daniel
COO
$4.15
211,041
$4.52
16,902
216,250
$4.55
13,827
160,437
$5.43
6,441
85,819
Llewelyn Linda
Chief People Officer
$5.76
86,044
$5.80
6,442
92,260
$7.52
2,500
72,250
$7.51
91,253
$6.93
4,500
69,938
Gallagher Duncan
$6.98
74,438
$7.88
98,702
$8.32
19,268
19,599
86,712
Alger Jason
CFO
$7.70
22,773
96,462
$8.94
7,500
236,950
Freeman Kevin Lee
Chief Commercial Officer
$8.50
1,365
112,910
129,690